Citations

Showing 10 of 108104 citations.

The endosomal pH regulator NHE9 is a driver of stemness in glioblastoma
Ko, Myungjun , Suárez-Meade, Paola , Mekile, Allatah X. , Lal, Bachchu , López-Bertoni, Hernando , Kozielski, Kristen , Green, Jordan J. , Laterra, John , Quiñones‐Hinojosa, Alfredo , Schiapparelli, Paula , Lopez-Bertoni, Hernando , Green, Jordan J , Quinones-Hinojosa, Alfredo , Rao, Rajini , Makena, Monish Ram

Mayo Clinic

PNAS Nexus | March 9, 2022 | Volume: 1 | Issue: 1 | Pages: No page available

10.1093/pnasnexus/pgac013 | PMID 35387234 Get It

Abstract A small population of self-renewing stem cells initiate tumors and maintain therapeutic resistance in glioblastoma (GBM). Given the limited treatment options and dismal prognosis for this disease, there is urgent need to identify drivers of stem cells that could be druggable targets. Previous work showed that the endosomal pH regulator NHE9 is upregulated in GBM and correlates with worse survival prognosis. Here, we probed for aberrant signaling pathways in patient-derived GBM cells and found that NHE9 increases cell surface expression and phosphorylation of multiple receptor tyrosine kinases (RTKs) by promoting their escape from lysosomal degradation. Downstream of NHE9-mediated receptor activation, oncogenic signaling pathways converged on the JAK2-STAT3 transduction axis to induce pluripotency genes Oct4 and Nanog and suppress markers of glial differentiation. We used both genetic and chemical approaches to query the role of endosomal pH in GBM phenotypes. Loss-of-function mutations in NHE9 that failed to alkalinize endosomal lumen did not increase self-renewal capacity of gliomaspheres in vitro. However, monensin, a chemical mimetic of Na+/H+ exchanger activity, and the H+ pump inhibitor bafilomycin bypassed NHE9 to directly alkalinize the endosomal lumen resulting in stabilization of RTKs and induction of Oct4 and Nanog. Using orthotopic models of primary GBM cells we found that NHE9 increased tumor initiation in vivo. We propose that NHE9 initiates inside-out signaling from the endosomal lumen, distinct from the established effects of cytosolic and extracellular pH on tumorigenesis. Endosomal pH may be an attractive therapeutic target that diminishes stemness in GBM, agnostic of specific receptor subtype.
Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting
Thygesen, Kristian , Jaffe, Allan S. , Jaffe, Allan S.

Mayo Clinic

European Heart Journal | March 9, 2022 | Volume: 43 | Issue: 25 | Pages: 2418-2420

10.1093/eurheartj/ehac147 | PMID 35296879 Get It

The Extracellular ATP Receptor P2RX7 Imprints a Promemory Transcriptional Signature in Effector CD8+ T Cells
Vardam-Kaur, Trupti , Dijk, Sarah van , Peng, Changwei , Wanhainen, Kelsey M. , Jameson, Stephen C. , Silva, Henrique Borges da , van Dijk, Sarah , Borges da Silva, Henrique , Jameson, Stephen C

Mayo Clinic

The Journal of Immunology | March 9, 2022 | Volume: 208 | Issue: 7 | Pages: 1686-1699

10.4049/jimmunol.2100555 | PMID 35264459 Get It

Abstract Development of CD8+ central memory T (Tcm) and resident memory T (Trm) cells, which promote immunity in the circulation and in barrier tissues, respectively, is not completely understood. Tcm and Trm cells may arise from common precursors; however, their fate-inducing signals are elusive. We found that virus-specific effector CD8+ T cells display heterogeneous expression of the extracellular ATP sensor P2RX7. P2RX7-high expression is confined, at peak effector phase, to CD62L+ memory precursors, which preferentially form Tcm cells. Among early effector CD8+ T cells, asymmetrical P2RX7 distribution correlated with distinct transcriptional signatures, with P2RX7-high cells enriched for memory and tissue residency sets. P2RX7-high early effectors preferentially form both Tcm and Trm cells. Defective Tcm and Trm cell formation in P2RX7 deficiency is significantly reverted when the transcriptional repressor Zeb2 is ablated. Mechanistically, P2RX7 negatively regulates Zeb2 expression, at least partially through TGF-β sensing in early effector CD8+ T cells. Our study indicates that unequal P2RX7 upregulation in effector CD8+ T cells is a foundational element of the early Tcm/Trm fate.
Diabetes Management for Community Paramedics: Development and Implementation of a Novel Curriculum
Kasper, Anna L., Carlson, Peter N., Johnson, Rachel F., Schultz, Jeffery L., Meyer, Dustin, Liedl, Chad P., Juntunen, Michael B. , McCoy, Rozalina G. , Myers, Lucas A. , McCoy, Rozalina Grubina

Mayo Clinic

Diabetes Spectrum | March 9, 2022 | Volume: 35 | Issue: 3 | Pages: 367-376

10.2337/ds21-0095 | PMID 36082010 Get It

Association of Lower Extremity Lymphedema With Physical Functioning and Activities of Daily Living Among Older Survivors of Colorectal, Endometrial, and Ovarian Cancer
Zhang, Xiaochen , McLaughlin, Eric , Naughton, Michelle J. , Bernardo, Brittany M., Allison, Matthew , Bea, Jennifer W. , Allison, Matthew A , Krok‐Schoen, Jessica L. , Cheville, Andrea , Stefanick, Marcia L , Paskett, Electra D.

Mayo Clinic

JAMA Network Open | March 9, 2022 | Volume: 5 | Issue: 3 | Pages: e221671

10.1001/jamanetworkopen.2022.1671 | PMID 35262713 Get It

Prevalence of Surgical Procedures at Symptomatic Onset of Prion Disease
Porter, Amanda , Prusinski, Christian , Lazar, Evelyn, Yuh, Clara, Bucelli, Robert C. , Day, Gregory S. , Porter, Amanda L, Prusinski, Christian C , Day, Gregory S , Appleby, Brian S.

Mayo Clinic

JAMA Network Open | March 9, 2022 | Volume: 5 | Issue: 3 | Pages: e221556

10.1001/jamanetworkopen.2022.1556 | PMID 35262719 Get It

Characteristics of Post-ICU and Post-COVID Recovery Clinics in 29 U.S. Health Systems
Danesh, Valerie, Boehm, Leanne M., Eaton, Tammy L., Arroliga, Alejandro C., Mayer, Kirby P., Kesler, Shelli R., Bakhru, Rita N., Baram, Michael, Bellinghausen, Amy L., Biehl, Michelle, Dangayach, Neha S., Goldstein, Nir M., Hoehn, K. Sarah, Islam, Marjan, Jagpal, Sugeet, Johnson, Annie B., Jolley, Sarah E., Kloos, Janet A., Mahoney, Eric J., Maley, Jason H., Martin, Sara F., McSparron, Jakob I., Mery, Marissa, Saft, Howard, Santhosh, Lekshmi, Schwab, Kristin, Villalba, Dario, Sevin, Carla M., Montgomery, Ashley A., Boehm, Leanne M. , Eaton, Tammy L. , Santhosh, Lekshmi , Danesh, Valerie , Mayer, Kirby P. , Arroliga, Alejandro C., Mayer, Kirby P., Kesler, Shelli R., Bakhru, Rita N., Baram, Michael, Bellinghausen, Amy L., Biehl, Michelle, Dangayach, Neha S., Goldstein, Nir M., Hoehn, K. Sarah, Islam, Marjan, Jagpal, Sugeet, Johnson, Annie B., Jolley, Sarah E., Kloos, Janet A., Mahoney, Eric J., Maley, Jason H., Martin, Sara F., McSparron, Jakob I., Mery, Marissa , Saft, Howard, Schwab, Kristin, Villalba, Darío Salvador , Sevin, Carla M., Montgomery, Ashley A.

Mayo Clinic

Critical Care Explorations | March 9, 2022 | Volume: 4 | Issue: 3 | Pages: e0658

10.1097/cce.0000000000000658 | PMID 35291316 Get It

OBJECTIVES: The multifaceted long-term impairments resulting from critical illness and COVID-19 require interdisciplinary management approaches in the recovery phase of illness. Operational insights into the structure and process of recovery clinics (RCs) from heterogeneous health systems are needed. This study describes the structure and process characteristics of existing and newly implemented ICU-RCs and COVID-RCs in a subset of large health systems in the United States. DESIGN: Cross-sectional survey. SETTING: Thirty-nine RCs, representing a combined 156 hospitals within 29 health systems participated. PATIENTS: None. INTERVENTIONS: None. MEASUREMENT AND MAIN RESULTS: RC demographics, referral criteria, and operating characteristics were collected, including measures used to assess physical, psychologic, and cognitive recoveries. Thirty-nine RC surveys were completed (94% response rate). ICU-RC teams included physicians, pharmacists, social workers, physical therapists, and advanced practice providers. Funding sources for ICU-RCs included clinical billing (n = 20, 77%), volunteer staff support (n = 15, 58%), institutional staff/space support (n = 13, 46%), and grant or foundation funding (n = 3, 12%). Forty-six percent of RCs report patient visit durations of 1 hour or longer. ICU-RC teams reported use of validated scales to assess psychologic recovery (93%), physical recovery (89%), and cognitive recovery (86%) more often in standard visits compared with COVID-RC teams (psychologic, 54%; physical, 69%; and cognitive, 46%). CONCLUSIONS: Operating structures of RCs vary, though almost all describe modest capacity and reliance on volunteerism and discretionary institutional support. ICU- and COVID-RCs in the United States employ varied funding sources and endorse different assessment measures during visits to guide care coordination. Common features include integration of ICU clinicians, interdisciplinary approach, and focus on severe critical illness. The heterogeneity in RC structures and processes contributes to future research on the optimal structure and process to achieve the best postintensive care syndrome and postacute sequelae of COVID outcomes.
CancerBERT: a cancer domain-specific language model for extracting breast cancer phenotypes from electronic health records
Zhou, Sicheng , Wang, Nan , Wang, Liwei , Zhang, Rui , Zhang, Rui , Liu, Hongfang

Mayo Clinic

Journal of the American Medical Informatics Association | March 9, 2022 | Volume: 29 | Issue: 7 | Pages: 1208-1216

10.1093/jamia/ocac040 | PMID 35333345 Get It

Abstract Objective Accurate extraction of breast cancer patients’ phenotypes is important for clinical decision support and clinical research. This study developed and evaluated cancer domain pretrained CancerBERT models for extracting breast cancer phenotypes from clinical texts. We also investigated the effect of customized cancer-related vocabulary on the performance of CancerBERT models. Materials and Methods A cancer-related corpus of breast cancer patients was extracted from the electronic health records of a local hospital. We annotated named entities in 200 pathology reports and 50 clinical notes for 8 cancer phenotypes for fine-tuning and evaluation. We kept pretraining the BlueBERT model on the cancer corpus with expanded vocabularies (using both term frequency-based and manually reviewed methods) to obtain CancerBERT models. The CancerBERT models were evaluated and compared with other baseline models on the cancer phenotype extraction task. Results All CancerBERT models outperformed all other models on the cancer phenotyping NER task. Both CancerBERT models with customized vocabularies outperformed the CancerBERT with the original BERT vocabulary. The CancerBERT model with manually reviewed customized vocabulary achieved the best performance with macro F1 scores equal to 0.876 (95% CI, 0.873–0.879) and 0.904 (95% CI, 0.902–0.906) for exact match and lenient match, respectively. Conclusions The CancerBERT models were developed to extract the cancer phenotypes in clinical notes and pathology reports. The results validated that using customized vocabulary may further improve the performances of domain specific BERT models in clinical NLP tasks. The CancerBERT models developed in the study would further help clinical decision support.
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
Brazg, Ron, Bhargava, Anuj , Thrasher, James, Latif, Kashif, Bode, Bruce W. , Bailey, Timothy S. , Horowitz, Barry , Cavale, Arvind R., Kudva, Yogish C. , Kaiserman, Kevin B. , Grunberger, George , Reed, John Chip, CHATTARAJ, SARNATH , ZHANG, GINA , Shin, John , Chen, Vivian , Lee, Scott W., Cordero, Toni L. , Rhinehart, Andrew S., Buckingham, Bruce A. , Bailey, Timothy S , Horowitz, Barry S , Kudva, Yogish C. , Cordero, Toni L , Vigersky, Robert A , Buckingham, Bruce , Garg, Satish K. , Reed, John H. Chip, Vigersky, Robert A.

Mayo Clinic

Diabetes Technology & Therapeutics | March 9, 2022 | Volume: 24 | Issue: 8 | Pages: 535-543

10.1089/dia.2021.0540 | PMID 35263188 Get It

Background: Standard insulin infusion sets (IISs) are to be replaced every 2 to 3 days to avoid complications and diabetic ketosis due to set failure. This pivotal trial evaluated the safety and performance of a new extended-wear infusion set (EIS) when used for 7 days by adults with type 1 diabetes (T1D). Methods: This single-arm, nonrandomized trial enrolled adults (18–80 years of age) with T1D, who used their own MiniMed™ 670G system with insulin lispro or insulin aspart and the EIS for up to 7 days, across 12 consecutive wears. Safety endpoints included incidence of serious adverse events (SAEs), serious adverse device effects (SADEs), unanticipated adverse device effects (UADEs), severe hypoglycemia (SevHypo), severe hyperglycemia (SevHyper), diabetic ketoacidosis (DKA), and skin infection. The EIS failure rate due to unexplained hyperglycemia (i.e., suspected occlusion), the overall EIS survival rate, glycemic control outcomes (i.e., A1C, mean sensor glucose and time spent in established glucose ranges), total daily insulin delivered, and satisfaction with the EIS were determined. Results: The intention to treat population ( n = 259, 48% men, 45.0 ± 14.1 years) wore a total of 3041 EIS devices. No SADE, UADE, or DKA events was reported. Overall rates of SAEs, SevHypo, SevHyper, and skin infection were 3.8, 2.5, 104.1, and 20.1 events per 100 participant-years. The rate of EIS failure due to unexplained hyperglycemia at the end of day 7 was 0.1% (95% confidence interval [CI]: 0.03–0.51) and 0.4% (95% CI: 0.16–1.00) for insulin lispro and aspart use, respectively. Overall EIS survival rate at the end of day 7 was 77.8% (95% CI: 76.2–79.3), glycemic control did not change, and participants reported greater satisfaction with the EIS compared with standard IISs worn before the study ( P < 0.001). Conclusions: This investigation demonstrates that the EIS, when worn for up to 7 days, was safe and rated with high satisfaction, without adversely affecting glycemic control in adults with T1D. Clinical Trial Registration number: NCT04113694 ( https://clinicaltrials.gov/ct2/show/NCT04113694 ).
Crossing the Virtual Chasm: Practical Considerations for Rethinking Curriculum, Competency, and Culture in the Virtual Care Era
Bolster, Marcy B. , Chandra, Shruti , Demaerschalk, Bart M. , Esper, Christine D. , Genkins, Julian Z. , Tan‐McGrory, Aswita , Christopherson, Laura A. , Demaerschalk, Bart M , Hayden, Emily M. , Schwamm, Lee H.

Mayo Clinic

Academic Medicine | March 9, 2022 | Volume: 97 | Issue: 6 | Pages: 839-846

10.1097/acm.0000000000004660 | PMID 35263303 Get It

Abstract Virtual care, introduced previously as a replacement for in-person visits, is now being integrated into clinical care delivery models to complement in-person visits. The COVID-19 pandemic sped up this process. The rapid uptake of virtual care at the start of the pandemic prevented educators from taking deliberate steps to design the foundational elements of the related learning environment, including workflow, competencies, and assessment methods. Educators must now pursue an informed and purposeful approach to design a curriculum and implement virtual care in the learning environment. Engaging learners in virtual care offers opportunities for novel ways to teach and assess their performance and to effectively integrate technology such that it is accessible and equitable. It also offers opportunities for learners to demonstrate professionalism in a virtual environment, to obtain a patient’s history incorporating interpersonal and communication skills, to interact with multiple parties during a patient encounter (patient, caregiver, translator, telepresenter, faculty member), to enhance physical examination techniques via videoconferencing, and ideally to optimize demonstrations of empathy through “webside manner.” Feedback and assessment, important features of training in any setting, must be timely, specific, and actionable in the new virtual care environment. Recognizing the importance of integrating virtual care into education, leaders from across the United States convened on September 10, 2020, for a symposium titled, “Crossing the Virtual Chasm: Rethinking Curriculum, Competency, and Culture in the Virtual Care Era.” In this article, the authors share recommendations that came out of this symposium for the implementation of educational tools in the evolving virtual care environment. They present core competencies, assessment tools, precepting workflows, and technology to optimize the delivery of high-quality virtual care that is safe, timely, effective, efficient, equitable, and patient-centered.